A Walking Pharmacy Calls for a Vitamin B12 Supplement: Q
This class of polyphenols have a lower redox potential than oxygen and superoxide radicals, making these antioxidants better suited to bind active oxygen (Duthie and Crozier, 2000)
Common Use Cases This section contains a list of the common use cases that are implemented using dSIPRouter SIP Trunking Using IP Authentication dSIPRouter enables an organization to start supporting SIP Trunking within minutes
doi: 10.1007/s00439-014-1478-5 146 ScalisiEMPecoraroRScalisiADragottoJBracchittaGZimboneMet al
FOXO4-DRI Key Research Facts Full name: FOXO4 D-Retro-Inverso peptide (FOXO4-DRI) Classification: Cell-penetrating senolytic peptide FOXO4/p53 protein-protein interaction inhibitor Design: D-retro-inverso isoform of FOXO4s p53-binding domain reversed sequence with all D-amino acids Binding target: p53 transactivation domain 2 (TAD2) displaces FOXO4 from the FOXO4-p53 complex Mechanism: FOXO4-DRI binds p53 TAD2 p53 nuclear exclusion p53 mitochondrial translocation BAX activation caspase-3 cleavage senescent cell-selective apoptosis Selectivity basis: FOXO4 is upregulated in senescent cells but expressed at low levels in most non-senescent adult cells selectivity is mechanistically conferred D-amino acid advantage: Proteolytic stability resistant to intracellular peptidases that would rapidly degrade equivalent L-amino acid sequences Structural characterisation: NMR structural models of FOXO4-DRI/p53TAD2 complex resolved (Nature Communications, 2025) confirms disordered-to-ordered transition upon binding Research cell types studied: IMR90 fibroblasts, TM3 Leydig cells, endothelial cells, chondrocytes, keloid fibroblasts, HCT116 cancer cells In vitro working concentration: 25 M used in multiple published studies for senescent cell apoptosis induction What Does FOXO4-DRI Do in Research
Risks and Side Effects No major side effects have been reported by generally healthy adults using schisandra however, most studies have investigated its effects on animals, not humans
